Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration.

× No keyword cloud information.

17 in total

Review 1. Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors: J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal: Heart Date: 2004-01 Impact factor: 5.994

2. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Authors: Scot H Simpson; Sumit R Majumdar; Ross T Tsuyuki; Dean T Eurich; Jeffrey A Johnson
Journal: CMAJ Date: 2006-01-17 Impact factor: 8.262

3. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.

Authors: T Reffelmann; H G Klues; P Hanrath; E R Schwarz
Journal: Heart Date: 2002-01 Impact factor: 5.994

4. Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.

Authors: Charles E Leonard; Colleen M Brensinger; Christina L Aquilante; Warren B Bilker; Denise M Boudreau; Rajat Deo; James H Flory; Joshua J Gagne; Margaret J Mangaali; Sean Hennessy
Journal: Diabetes Care Date: 2018-02-02 Impact factor: 19.112

Review 5. Advances in pharmacologic therapies for type 2 diabetes.

Authors: Linde M Morsink; Mark M Smits; Michaela Diamant
Journal: Curr Atheroscler Rep Date: 2013-02 Impact factor: 5.113

Review 6. Comparative tolerability of sulphonylureas in diabetes mellitus.

Authors: A D Harrower
Journal: Drug Saf Date: 2000-04 Impact factor: 5.606

Review 7. Coronary artery disease and diabetes mellitus.

Authors: Doron Aronson; Elazer R Edelman
Journal: Cardiol Clin Date: 2014-06-10 Impact factor: 2.213

Review 8. Mitochondria as a drug target in ischemic heart disease and cardiomyopathy.

Authors: Andrew M Walters; George A Porter; Paul S Brookes
Journal: Circ Res Date: 2012-10-12 Impact factor: 17.367

9. Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.

Authors: Adelaide M Arruda-Olson; Richard K Patch; Cynthia L Leibson; Adrian Vella; Robert L Frye; Susan A Weston; Jill M Killian; Véronique L Roger
Journal: Mayo Clin Proc Date: 2009 Impact factor: 7.616

10. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

Authors: Ioanna Tzoulaki; Mariam Molokhia; Vasa Curcin; Mark P Little; Christopher J Millett; Anthea Ng; Robert I Hughes; Kamlesh Khunti; Martin R Wilkins; Azeem Majeed; Paul Elliott
Journal: BMJ Date: 2009-12-03